Reference Curve on Bone Mineral Density in Men (COURDO2)

September 22, 2023 updated by: Centre Hospitalier Régional d'Orléans
In men, the hope of lower life, the absence of equivalent of menopause and the existence of a higher peak bone mass are the three factors that explain the lower incidence of osteoporosis in men.

Study Overview

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Amiens, France, 80054
        • CHU Amiens
      • Paris, France, 75010
        • Hopital Lariboisiere
      • Saint-Étienne, France, 42055
        • CHU de Saint Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male
  • Aged between 20 and 30 years
  • Caucasians

Exclusion Criteria:

  • Lack of express consent
  • Pieces of metal or plastic parts in field
  • Diseases which cause technical difficulties for the correct evaluation of the hip and spine (severe dysplasia, hip surgery or lumbar spine)
  • Adult protect buy the law

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bone Mineral Density
Bone densitometry measurement: measurement of bone mineral densitometry with bone densitometry
Bone densitometry and measurement of body composition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone mineral density of the spine
Time Frame: Day 0
to establish reference curves in elderly mal volunteers from 20 to 30 years through the assessment of bone mineral density of the spine
Day 0
Bone mineral density of the hip
Time Frame: Day 0
to establish reference curves in elderly mal volunteers from 20 to 30 years through the assessment of bone mineral density of the hip
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fat mass of the body
Time Frame: day 0
to establish reference curves in elderly mal volunteers from 20 to 30 years through the assessment of body composition
day 0
Lean mass of the body
Time Frame: day 0
to establish reference curves in elderly mal volunteers from 20 to 30 years through the assessment of body composition
day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eric LESPESSAILLES, CHR Orléans

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2020

Primary Completion (Actual)

August 18, 2023

Study Completion (Actual)

August 18, 2023

Study Registration Dates

First Submitted

December 7, 2017

First Submitted That Met QC Criteria

January 15, 2018

First Posted (Actual)

January 17, 2018

Study Record Updates

Last Update Posted (Actual)

September 25, 2023

Last Update Submitted That Met QC Criteria

September 22, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • CHRO-2017-10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Mineral Density

Clinical Trials on Bone densitometry measurement

3
Subscribe